Search

everythinglearnresearchcommunity

for

Search:↓

Using 17-hydroxyprogesterone levels to diagnose nonclassic congenital adrenal hyperplasia can result in many incorrect diagnoses.

Researchers created a mouse model of a type of rickets that does not cause hair loss.

Premature balding in some men may be linked to altered hormones, but it's not the male equivalent to polycystic ovary syndrome or metabolic syndrome.

The study found that women with hyperandrogenic PCOS have higher levels of AKT1 and AKT2 proteins in their cells, which may lead to cell dysfunction.

Chemotherapy causes hair loss starting soon after treatment begins and recovers about 3 months after ending, while tamoxifen does not significantly affect hair growth.

Early diagnosis and treatment are key to managing health risks in teens with PCOS.

Gene linked to common hair loss found, may lead to new treatments.

FPHL causes hair loss in women due to genetics and hormones; minoxidil and anti-androgens are treatments, and early intervention is advised.

Treatment can improve survival and symptoms in dogs with Cushing's disease, but outcomes are unpredictable.

The oral glucose tolerance test is effective in detecting abnormal glucose tolerance in Indian women with PCOS.

Low-level laser therapy seems to help dogs with noninflammatory alopecia grow hair back.

Many treatments for hair loss lack proper testing and FDA approval, so their effectiveness is uncertain.

Lack or blocking of SRD5a, a key component in hormone creation, can lead to conditions like pseudohermaphrodism and affect hair growth, bone mass, muscle strength, and reproductive health. More research is needed on its regulation from fertilization to adulthood.

Transgender patients need proper skin care, especially when undergoing hormone treatments, to manage issues like acne and hair loss.

Obese and non-obese women with PCOS have higher heart risk markers, especially if they are obese.

Greek women with PCOS have a higher risk of metabolic syndrome and are more likely to be overweight compared to healthy controls.

The Random Forest algorithm was the most accurate at diagnosing Polycystic Ovarian Syndrome.

The conclusion is that removing both ovaries is the best treatment for excess male hormones in postmenopausal women, with medication as another option, and managing insulin resistance is important for diagnosis and treatment.

New research is needed to create better drugs that block the enzyme responsible for conditions like male baldness and prostate enlargement.

The N363S gene variant does not cause higher adrenal androgen levels in women with polycystic ovary syndrome.

The document concludes that topical minoxidil therapy is safe and effective in promoting hair growth for male pattern baldness.

Hair growth is influenced by factors like genetics and nutrition, and more research is needed to understand hair loss and growth mechanisms.

Isotretinoin improves severe acne without changing androgen or insulin levels but may increase body weight and triglycerides.

FAI values above 6.4 may suggest high androgen levels and increased metabolic risks in Chinese women of reproductive age.

Unwanted facial hair significantly impacts over 40% of women's psychological and social well-being, and various treatment options are available.

Electro-acupuncture may help treat PCOS in rats by changing brain DNA methylation.

The document concludes that diagnosing PCOS in teenagers is difficult and should focus on specific hormone levels and menstrual irregularities, while also considering treatment for symptoms and related health issues.

Treating hirsutism in women often requires a mix of medications and cosmetic methods for best results.

Cyproterone acetate is effective for treating hirsutism, but some patients may feel worse on low-dose maintenance therapy.

Researchers developed a model to predict how well certain compounds can block an enzyme related to hair loss and prostate issues, suggesting a 50 mg dose of finasteride might be effective based on lab and body data.